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Abstract
Epithelial–mesenchymal transformation of the embryonic epicardium produces the subepicardial mesenchyme that is essential for normal
coronary vascular development. Gene targeting experiments in mice have demonstrated an essential role for 4-integrin in normal epicardial
development, but the precise cellular consequences of 4-integrin loss remain uncertain. To better understand the function of 4-integrin
in epicardial development, we constructed a replication-incompetent adenovirus (AdlacZ4AS) that expresses antisense chicken 4-integrin
as the 3 untranslated region of a lacZ reporter gene. This construct effectively labeled cells while greatly reducing levels of 4-integrin
mRNA and protein. In quail chick chimeras, transplanted epicardial cells infected with AdlacZ4AS adhered to the heart and were
incorporated into the epicardium, but 4 days after grafting, were largely absent from the epicardial epithelium, recapitulating the defect in
4-null mice. This did not result from epicardial cell apoptosis or anomalous migration of epicardial cells to extracardiac sites. Rather,
AdlacZ4AS-infected epicardial cells were particularly invasive, being three to four times more likely to migrate to the interstitium of the
myocardium than AdlacZ-infected epicardial cells. Accelerated epicardial–mesenchymal transformation and migration of 4-negative
epicardium was observed in an organ culture system that does not require prior culture of epicardial cells. Remarkably, AdlacZ4AS
infection also prevented targeting of epicardially derived mesenchyme to the media of developing coronary vasculature in the myocardial
interstitium. This study provides evidence that epicardial 4-integrin normally restrains epicardial–mesenchymal transformation, invasion,
and migration and is essential for correct targeting of epicardially derived mesenchyme to the developing coronary vasculature.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The formation of epicardium from proepicardium is an
essential process in normal cardiac development at least in
part because the epicardium provides precursor cells to the
coronary vascular plexus forming in the subepicardial space
(Mikawa and Fischman, 1992; Mikawa and Gourdie, 1996;
Vrancken Peeters et al., 1999; Manner et al., 2001). This is
accomplished through epithelial–mesenchymal transforma-
tion of the epicardium, and the subepicardial mesenchyme
thus produced is the source of coronary vascular smooth
muscle and adventitial precursors (Dettman et al., 1998;
Pomares-Perez et al., 1998; Vrancken Peeters et al., 1999).
While a number of epicardial markers have been described,
including cytokeratin (Vrancken Peeters et al., 1995), 4-
integrin (Yang et al., 1995, Kwee et al., 1995; Pinco et al.,
2001; Sengbusch et al., 2002), bves (Reese et al., 1999;
Wada et al., 2001), epicardin (Robb et al., 1998), and wt1
(Moore et al., 1999; Carmona et al., 2001), relatively little
is known about the factors that regulate normal epicardial
development.
Epicardial–mesenchymal transformation is a complex
process in which some epicardial cells undergo mesenchy-
mal transformation to invade the subepicardial space or
myocardial interstitium, while others remain in the epicar-
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Fig. 1. Antisense to chicken integrin-4 is expressed by AdlacZ4AS and knocks down endogenous integrin-4 transcripts and protein. (A) Construction of
replication-defective AdlacZ4AS adenovirus. We first created -galactosidase-expressing AdlacZ by cloning a 3.0-Kb lacZ gene containing a nuclear
localization signal into pAdTrackCMV. This placed the lacZ gene under the control of the CMV promoter (arrow) and placed it in a head-to-tail orientation
with the CMV-GFP gene in pAdTrackCMV. Both genes are positioned upstream of SV40 polyadenylation signals (PA). Arrows indicate the direction with
which the genes are transcribed. AdlacZ4AS was then constructed by placing a 1.3-Kb partial chick 4 cDNA in its antisense orientation (4AS) between
tandem stop codons in lacZ and 5 of the SV40 polyadenylation signal of pAdTrackCMVlacZ. This resulted in a chimeric mRNA in which the structural gene
encodes nuclear localized lacZ and the 3 untranslated is an antisense sequence to chicken integrin 4. (B) Equivalent cultures of 1  106 chick myoblasts
were either left uninfected or infected with AdlacZ4AS. Total RNA was harvested from one infected () and one uninfected () plate every day for 3 days.
Northern analysis was performed on these samples by using a double-stranded DNA probe to the 4 cDNA. (C–K) Cultured epicardial cells were either
infected with AdlacZ (C–E), AdlacZ4AS (F–H), or left uninfected (I–K). Cultures were maintained in serum-free medium for 1 week and then fixed and
stained with anti-gal (C, F, I), anti-4 (D, G, J), and dapi (E, H, K). Cells infected with AdlacZ reacted with anti-gal (C) and anti-4 (D). Cells infected
with AdlacZ4AS reacted with anti-gal (F), but not anti-4 (G). Uninfected cells did not react with anti-gal (I) but did react with anti-4 (J). Magnification
bar in (K) represents 40 m for all panels.
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dium. Our previous results implicate FGF signaling in stim-
ulating and TGF signaling in antagonizing epicardial–
mesenchymal transformation (Morabito et al., 2001). We
reasoned that cell–extracellular matrix (ECM) interactions
may also play an essential role in determining whether
epicardial cells delaminate to form mesenchyme. Cellular
interactions with the ECM are executed by integrin recep-
tors (Ruoslahti, 1996; Hynes, 2002). Integrins are conserved
cell surface receptors that are known to function during cell
adhesion, cell migration, and in ligand-mediated cell signal-
ing (Schwartz et al., 1995; Giancotti and Ruoslahti, 1999).
The hypothesis that the epicardium requires integrin func-
tion is supported by targeted deletions of the 4-integrin
gene (Itga4) in mice (Yang et al., 1995; Sengbusch et al.,
2002). Two strategies have been employed in targeting the
Itga4 locus: a classic knock-out strategy (Yang et al., 1995)
and a lacZ knock-in strategy (Sengbusch et al., 2002). In
both cases, 50% of the homozygous embryos died at em-
bryonic day 11 (E11) due to defects in chorioallantois fu-
sion, and the other 50% lived to E12 and had craniofacial
abnormalities and pericardial hemorrhaging. In the hearts of
E11 and older 4 knock-out embryos, the epicardium was
missing on the entire surface of the heart, and coronary
vessels in the atrioventricular sulcus did not form. In hearts
of the original knockout, the epicardium migrated to cover
the heart byE10, but then disappeared (Yang et al., 1995).
This observation implicated 4 function in the adhesion of
the epicardium to the myocardium but not in migration of
epicardial cells from the proepicardial organ.
While gene targeting studies in the mouse support a role
for 4-integrin in the migration of epicardial cells on the
myocardium and long-term maintenance of the epicardium,
these studies have not investigated the role of 4-integrin in
epicardial–mesenchymal transformation, subsequent migra-
tion, or cell fate determination. In addition, studies in the
mouse may be limited by the secondary effects of the
placentation defect, pericardial hemorrhage, and ultimately
the death of the embryo. To investigate further the role of
4-integrin in epicardial development, we developed a
novel antisense strategy to simultaneously label and inhibit
4-integrin expression in quail epicardial cells. We then
studied 4-negative epicardial cells in vitro and trans-
planted them into stage-appropriate chick hosts so that their




Replication defective adenoviral constructs were created
by using the vectors designed by He and Voglestein (1998).
To construct AdlacZ, we cloned a 3.0-Kb lacZ gene con-
taining a nuclear localization signal into the cloning site of
pAdTrackCMV (He and Voglestein, 1998). This created a
plasmid called pAdTrackCMVlacZ that was recombined
with pAdEasy-1 to produce the pAdlacZ plasmid. Virus
produced by this construct expresses cytoplasmic GFP and
nuclear-localized -galactosidase. To construct AdlacZ4AS,
we cloned a 1.3-Kb chick 4 cDNA fragment (Stepp et al.,
1994) in antisense orientation into pAdTrackCMVlacZ be-
tween the lacZ gene and the SV40 polyadenylation signal
similar to Galileo et al. (1992). The resulting plasmid,
pAdTrackCMVlacZ4AS, was recombined with pAdEasy-1 to
produce the plasmid pAdlacZ4AS. Adenoviral plasmids were
transfected into human kidney 293 cells by electroporation in
4-mm gap cuvettes at 260 volts and 960 F. Viral supernatants
were produced, and viruses were amplified by using the pro-
tocol of He and Voglestein (1998).
Table 1
Summary of AdlacZ and AdlacZ4AS grafts
E3.5/E4.5 E6.5 E17.5
AdlacZ 5/6 4/4 4/4
AdlacZ4AS 2/4 4/7 2/11
Note. Results of 36 grafts of either AdlacZ- or AdlacZ4AS-infected
epicardial cells into E2.5 chick hosts. Chimeric embryos were fixed 1, 2, 4,
or 15 days after the surgery. For each column, the number on the right is
the total number of hearts fixed for that time point, and the number on the
left is the number of hearts in which blue cells were observed on the
surface of the heart.
Fig. 2. Results from chimeras fixed after 1 or 2 days. Results from 10 grafted hearts fixed 1–2 days after the grafting surgery. Hearts were stained in whole
mount in lacZ staining buffer containing Bluogal, inspected for blue cells (Table 1), and then embedded in paraffin. Hearts were sectioned, and cells with
blue nuclei were counted for their position in epicardium, subepicardial space, or myocardium (Table 2). Sections show representative hearts grafted with
cells infected with AdlacZ (A) and AdlacZ4AS (B). Grafted cells infected with AdlacZ (A) or AdlacZ4AS (B) initially attached to the heart in clusters (*).
Infected cells were observed moving into the epicardium and myocardium (arrowheads). (C) Bar graph showing the total quantification of lacZ cells in these
10 grafts. Bars are mean values of the percent of cells scored in the epicardium, subepicardium, or myocardium for grafted cells infected with AdlacZ (white
bars) and grafted cells infected with AdlacZ4AS (black bars). Sample size is n  6 for AdlacZ and n  4 for AdlacZ4AS. Abbreviations are: myo,
myocardium; epi, epicardium; and peo, proepicardial organ. Magnification bars are 40 m.
Fig. 3. Results from chimeras fixed after 4 days. Results from 11 grafted hearts fixed 4 days after the grafting surgery. Hearts were fixed and stained as above.
Sections show representative hearts grafted with cells infected with AdlacZ (A) and AdlacZ4AS (B). (C) Bar graph showing the total quantification of lacZ
cells in these 11 grafts. Bars are mean values of the percent of cells scored in the epicardium, subepicardium, or myocardium for grafted cells infected with
AdlacZ (white bars) and grafted cells infected with AdlacZ4AS (black bars). Sample size is n  4 for AdlacZ and n  7 for AdlacZ4AS. Error bars are
standard error of the mean. P values above the bars result from a Student’s t test. Abbreviations are: myo, myocardium; epi, epicardium; avs, atrioventricular
sulcus; and avc, atrioventricular cushions. Embossed arrowhead in (C) points to labeled cells in the subepicardial matrix. Magnification bars are 40 m.
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Chick eggs and surgeries
White leghorn chicken (Gallus gallus) eggs were purchased
from Sharp Sales (West Chicago, IL), and Japanese Quail
embryos (Cotournix cotournix japonicum) were purchased
from Strickland Farms (Pooler, GA) and incubated in a hu-
midified incubator at 37°C. For grafting surgeries, we win-
dowed eggs at E2.5 of incubation and closed the window with
Parafilm. Grafts were done as described in Dettman et al.
(1998). In this case, quail epicardial cells were infected for 4 h
and washed several times in Dulbecco’s PBS (DPBS) prior to
subsequent manipulations. Grafted hearts were fixed in form-
aldehyde (4% vol/vol in DPBS) made from paraformaldehyde
(EM Sciences) for 30 min and washed in DPBS. -Galac-
tosidase activity was monitored by soaking hearts in lacZ
staining buffer containing 1 mg/ml Bluo-Gal (Invitrogen). For
sectioning, hearts were dehydrated through ethanol and cleared
in CitriSolv (Fisher) before embedding in paraffin.
Northern analysis
Total RNA from chick myoblasts was extracted by using
Trizol reagent (Invitrogen). RNA was quantified with a
spectrophotometer, and equivalent OD units were loaded
onto formaldehyde–agarose gels. Gels, Northern transfers,
and hybridizations were done by using the Northern Max
system of Ambion. Blots were probed with double-stranded
DNA probes labeled with 32P-dATP by the random hex-
anucleotide method. We used three probes: 3.0-Kb lacZ,
1.3-Kb chicken 4 cDNA, and -actin to monitor loading of
equal amounts of total RNA.
Cell culture and adenovirus infection
Chick epicardial cells were cultured in serum-free M199
according to the heart explant method of Dettman et al.
(1998). E4.5 chick hearts were explanted either into tissue
culture-treated dishes (Corning Costar) or onto glass cov-
erslips coated with human serum fibronectin (BD Bio-
sciences). To stimulate smooth muscle differentiation of
chick epicardial cells, recombinant human PDGF-BB (R&D
Systems) was added to M199 medium supplemented with
fetal bovine serum (10% vol/vol) to a final concentration of
20 ng/ml. Primary chick myoblasts were made from E12
breast muscle and cultured in myoblast medium according
to the method of Antin and Ordahl (1991). Human embry-
onic kidney 293 cells were obtained from ATCC and cul-
tured in DMEM supplemented with fetal bovine serum
(10% vol/vol). All cultured cells (epicardial cells, myo-
blasts, and 293 cells) were infected with adenovirions in
complete medium for 1–4 h at 37°C with a multiplicity of
infection of 100 virions per cell. Viral concentration was
estimated by spectrophotometry. Prior to infection, cells were
washed with DPBS 3 times and then incubated in complete or
serum-free medium as described. For all cell types, titering
experiments were done with either AdlacZ or AdlacZ4AS by
diluting viral stocks, infecting for 1 h at 37°C, culturing for
1–2 days, and monitoring GFP expression in cells.
Organ culture assays
E5.5 (HH 28) hearts were excised from chick embryos in
sterile DPBS and placed in serum-free M199 medium. Me-
dium was then replaced with serum-free M199 or serum-free
M199 supplemented with 20 ng/ml recombinant human FGF-2
(R&D Systems) and 50 l of AdlacZ at 1  109 pfu/ml
(approximately 5  107 virions). Hearts were incubated over-
night at 37°C in a 5% CO2 incubator. Hearts were washed in
serum-free M199 and then incubated in serum-free M199 or
serum-free M199 supplemented with 20 ng/ml FGF-2 for 2
days. Hearts were then fixed in formaldehyde (4% vol/vol in
DPBS) made from paraformaldehyde (EM Sciences).
Immunohistochemistry
Cells were grown on fibronectin-coated coverslips. After
treatments, cells were washed in DPBS and fixed in ice-cold
methanol. Fixed cells were washed in DPBS and PBT
[DPBS with 0.1% (wt/vol) bovine serum albumin and 0.1%
(vol/vol) Tween 20] prior to incubation in antibodies diluted
in PBT. Paraffin-embedded hearts were rehydrated through
an ethanol series into water. Sections were then washed in
Fig. 4. Epicardial cells infected with AdlacZ4AS migrate to the myocardium in organ culture in vitro. Organ culture experiments in which E4.5 chick hearts
were infected for four hours with either AdlacZ or AdlacZ4AS and then cultured for 3 days in serum-free medium. Sections show representative hearts
grafted with cells infected with AdlacZ (A) and AdlacZ4AS (B). Arrowheads point to lacZ cells in the myocardium. Cells were scored for their position
in epicardium, subepicardial space, or myocardium. (C) Bar graph showing the total quantification of lacZ cells in hearts cultured in serum-free medium.
Bars are the mean percent of cells scored in the epicardium, subepicardium, or myocardium in alternate sections (10 m) of hearts infected with AdlacZ (white
bars) and grafted cells infected with AdlacZ4AS (black bars). Sample size is n  6 for AdlacZ and n  4 for AdlacZ4AS. (F) Error bars are standard error
of the mean. P values above the bars result from a Student’s t test. Abbreviations are: myo, myocardium; and epi, epicardium. Magnification bars are 40 m.
Fig. 5. Stimulation of epicardial–mesenchymal transformation by FGF-2 in combination with AdlacZ4AS infection increases migration of epicardially
derived mesenchyme to the myocardium. Organ culture experiments in which E4.5 chick hearts were infected for 4 h with either AdlacZ or AdlacZ4AS and
then cultured for 3 days in serum-free medium supplemented with 20 ng/ml FGF-2. Sections show representative hearts grafted with cells infected with
AdlacZ (A) and AdlacZ4AS (B). (C) Bar graph showing the total quantification of lacZ cells in hearts when epicardial–mesenchymal transformation is
stimulated by FGF-2. Bars are the mean percent of cells scored in the epicardium, subepicardium, or myocardium in alternate sections (10 m) of hearts
infected with AdlacZ (white bars) and grafted cells infected with AdlacZ4AS (black bars). Sample size is n  3 for AdlacZ-infected hearts and n  4 for
AdlacZ4AS-infected hearts. Error bars are standard error of the mean. P values above the bars result from a Student’s t test. Abbreviations are: myo,
myocardium; and epi, epicardium. Magnification bars are 40 m.
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DPBS for 30 min before incubating with diluted antibodies
as above. The following antibodies were used: pan anti-
cytokeratin (Dako) and rabbit polyclonal anti-human 4
integrin, specific for the cytoplasmic domain of 4 (Chan et
al., 1991). Monoclonal anti-caldesmon clone CALD-5
(Sigma) was used to identify vascular smooth muscle cells
in grafted hearts or in cultured epicardial cells. Monoclonal
anti-calponin (Sigma) was used to identify epicardial cells
that had differentiated into smooth muscle in vitro.
TUNEL analysis
Terminal deoxynucleotidyl transferase (TdT) analysis
(TUNEL) was performed on sections of grafted hearts con-
taining lacZ-positive nuclei. Slides were postfixed in para-
formaldehyde (4% vol/vol), washed in Dulbecco’s PBS, and
treated with proteinase K (10 g/ml) before incubating with
TdT reaction mix containing fluorescein-12-dUTP (Pro-
mega) for 1 h at 37°C Slides were washed in 2[times] SSC
buffer and Dulbecco’s PBS, and then mounted in Vecta-
shield mounting medium (Vector Labs). Slides were imaged
by indirect immunofluorescence.
Results
Construction of a recombinant adenovirus expressing
antisense chicken 4
To test the hypothesis that 4 functions in epicardial
cells during epicardial–mesenchymal transformation and/or
Table 2
Scoring of epicardial cell grafts
A. Grafts sacrificed at E3.5 or E4.5
Graft Epicardium Subepicardium Myocardium Total
AdlacZ 1 207 (59%) 63 (18%) 82 (23%) 352
2 153 (29%) 272 (52%) 95 (18%) 520
3* 0 (0%) 30 (29%) 72 (71%) 102
4 28 (40%) 19 (27%) 23 (33%) 70
5 27 (27%) 21 (21%) 53 (53%) 101
6 42 (43%) 10 (10%) 46 (47%) 98
Total 457 415 371 1243
Average cells scored per chimera 207
AdlacZ4AS 1 57 (15%) 23 (6%) 308 (79%) 388
2* 28 (8%) 19 (6%) 296 (86%) 343
3* 22 (9%) 16 (7%) 195 (84%) 233
4 46 (13%) 9 (3%) 295 (84%) 350
Total 153 67 1094 1314
Average cells scored per chimera 329
B. Grafts sacrificed at E6.5
Graft Epicardium Subepicardium Myocardium Total
AdlacZ 1 126 (24%) 272 (53%) 118 (23%) 516
2 19 (7%) 89 (33%) 161 (60%) 269
3 872 (49%) 637 (36%) 263 (15%) 1772
4 132 (32%) 227 (56%) 48 (12%) 407
Total 1149 1225 590 2964
Average cells scored per chimera 741
AdlacZ4AS 1 27 (6%) 55 (12%) 376 (82%) 458
2 0 (0%) 95 (40%) 144 (60%) 239
3* 0 (0%) 19 (24%) 61 (76%) 80
4 3 (1%) 128 (38%) 207 (61%) 338
5* 0 (0%) 43 (16%) 233 (84%) 276
6 10 (3%) 84 (28%) 207 (69%) 301
7* 0 (0%) 0 (0%) 214 (100%) 214
Total 40 424 1442 1906
Average cells scored per chimera 272
Note. All values are rounded up to the nearest whole number. Grafted embryos were allowed to develop for 1 or 2 days (A) or 4 days (B) before they were
fixed and stained in Bluo-Gal buffer. Graft number is indicated in column 1. Star indicates graft from Table 1 where there were no obvious blue cells on
the heart. Embryos were sectioned and labeled cells were scored for their presence in epicardium (column 2), subepicardium (column 3), or myocardium
(column 4). Total in column 5 indicates the total number of grafted cells scored for each graft and totals in rows indicate the sum of scored cells for each
column. Percentages in parenthesis across rows indicate the percentage of each cell-type for that graft. Average values in rows indicate the average total
number of cells scored per chimera for each experiment.
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subsequent migration and differentiation of epicardially de-
rived mesenchyme, we set out to inhibit chick 4-integrin in
epicardial cells using a replication-defective adenovirus ex-
pressing an antisense 4 sequence. We constructed two
viruses for cell labeling using the “AdEasy” system of He
and Voglestein (1998). The control virus, AdlacZ, encodes
two reporter genes: CMV-GFP and CMV-lacZ (Fig. 1A).
We used a lacZ gene containing a nuclear localization signal
to achieve lacZ expression that is compatible with cytoplas-
mic GFP expression and that is more easily identifiable in
single cells. We produced the 4 antisense virus
AdlacZ4AS by inserting a 1.3-Kb 4 antisense sequence
into the 3 untranslated region of the lacZ gene. Because the
4 antisense sequence is expressed as part of the lacZ
Fig. 6. AdlacZ4AS-infected cells form vascular smooth muscle in the myocardium at a reduced rate. Views of paraffin sections of E17.5 chimeric hearts
(A, B) grafted with AdlacZ4AS-infected epicardial cells. Sections were stained with monoclonal anti-caldesmon to identify vascular smooth muscle cells.
Asterisks indicate vessels, and arrowheads indicate lacZ-positive cells. (C) Quantification of the percentage of myocardial lacZ-positive cells that were also
caldesmon-positive in E17.5 chimeric hearts grafted with either AdlacZ (white bar) or AdlacZ4AS (black bar) infected cells. Sample size was n  4 for
AdlacZ-infected cells and n  5 for AdlacZ4AS-infected cells. Error bars are standard error of the mean. P values above the bars result from a Student’s
t test. Magnification bars represent 40 m.
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mRNA, expression of lacZ and -galactosidase activity
served as an indicator that the 4 antisense sequence was
expressed in cells infected with AdlacZ4AS.
We tested AdlacZ4AS for inhibition of 4-integrin ex-
pression in chicken myoblasts (Fig. 1B). Chicken myoblasts
were chosen because of their ease of culture and high
expression 4-integrin (Testaz and Duband, 2001). In un-
infected cells, an 4-integrin probe hybridized to a single
band of 4.6-Kb corresponding to wild-type 4 mRNA. In
cells infected with AdlacZ4AS for 24 h, we observed two
bands, the 4 mRNA and a 4.3-Kb band corresponding to
the lacZ4AS transcript (Fig. 1B). In a separate experiment,
we confirmed that this band also hybridized to a lacZ probe
(not shown). After 48 h of infection, we observed that the
endogenous 4 band was depleted and the antisense tran-
script was more intense. By 72 h, the endogenous 4 band
was undetectable in infected cells. Blots were hybridized
with a probe to -actin, and densitometry was performed to
quantify the reduction of 4 mRNA levels caused by infec-
tion with AdlacZ4AS. We found that 4 mRNA levels
were reduced by approximately 90% in chick myoblast
cultures infected with AdlacZ4AS. Parallel myoblast cul-
tures were fixed for -gal staining and showed that 90% of
myoblasts were infected with AdlacZ4AS, suggesting that
residual 4 mRNA observed in the Northern experiment
was derived from the population of uninfected cells. We
concluded from this experiment that antisense sequences
expressed by AdlacZ4AS effectively reduced 4 mRNA
levels in cells that normally express high levels of 4-
integrin.
To determine whether 4 protein levels are reduced in
epicardial cells infected with AdlacZ4AS, we infected pri-
mary cultures of quail epicardial cells with AdlacZ or
AdlacZ4AS. Cells were incubated for 7 days before fixa-
tion and indirect immunofluorescence to confirm long-last-
ing expression of each construct (Fig. 1C–K). With both
constructs, nearly every cell was infected and gal protein
was readily detected (Fig. 1C and F). In cells infected with
AdlacZ, 4-integrin was also present (Fig. 1D). In
AdlacZ4AS-infected cultures, 4-protein was absent from
nearly every cell (Fig. 1G), demonstrating that 4-integrin
is effectively reduced in quail epicardial cells infected with
AdlacZ4AS. In addition, we observed that 4 inhibition
did not alter cell morphology within the epicardial epithe-
lium.
Antisense reduction of 4 in epicardial cells alters their
position within chimeric embryos
We previously showed that quail epicardial cells cultured
in serum-free medium can be grafted to E2.5 chick hearts
and that transplanted cells participate in normal epicardial
development (Dettman et al., 1998). Similar results were
obtained with grafts of the quail proepicardial organ (Perez-
Pomares et al., 1998; Gittenberger-de Groot et al., 1998),
indicating that culturing of epicardial cells does not affect
their developmental potential. To test the function of epi-
cardial 4-integrin during cardiac development, we grafted
quail epicardial cells infected with either AdlacZ or
AdlacZ4AS into the pericardial space of E2.5 chick hosts.
Because 4 mRNA was not fully depleted from chick myo-
blasts until 2–3 days after infection and 4 antisense inhi-
bition appeared to persist for at least 7 days (Fig. 1), we
incubated virus-infected epicardial cells for 4 days in se-
rum-free medium prior to grafting these cells into chick
hosts. Epicardial cells infected with either AdlacZ or
AdlacZ4AS retained a normal epithelial morphology when
maintained in serum-free medium for periods of at least 7
days (Fig. 1D).
We grafted chick epicardial cells infected with either
AdlacZ or AdlacZ4AS to the myocardial wall of E2.5 chick
embryos, an age when the proepicardium is attaching to the
heart but before the epicardium has migrated over the myo-
cardial surface. We then allowed grafted embryos to de-
velop for 1, 2, 4, or 15 days before hearts were explanted
and stained to visualize -gal activity. Initially, hearts were
inspected for blue cells on the surface of grafted hearts
(Table 1). Thirteen of fourteen hearts containing AdlacZ-
infected grafts contained readily detectable patches of blue
cells on the surface of the heart similar to quail-chick
chimeras in our previous study (Dettman et al., 1998). In
contrast, we observed epicardial staining in only 8 of 22
hearts containing AdlacZ4AS-infected grafts, and the loss
of epicardial staining was particularly prominent in embryos
incubated for 15 days after transplantation. We also saw
fewer patches of smaller size in AdlacZ4AS-infected grafts
relative to the AdlacZ control hearts. The absence of 4-
negative cells in the epicardial epithelium recapitulates the
primary finding in 4-null mice (Yang et al., 1995).
To explain this difference, we considered the following
four alternatives. First, AdlacZ4AS infection may have
promoted apoptosis in grafted cells, resulting in their death.
Second, AdlacZ4AS infection may have prevented grafted
epicardial cells from adhering to the heart resulting in their
apparent loss. Third, AdlacZ4AS infection may have
caused infected epicardial cells to adhere and migrate to
other surrounding tissues, such as the parietal pericardium
or liver. Finally, AdlacZ4AS infection may have altered the
position of grafted cells within the heart into deeper and
therefore hidden positions. To determine what happened to
epicardial cells infected with AdlacZ4AS, we sectioned
chimeric embryos or hearts fixed either 1, 2, 4, or 15 days
after the surgery.
To investigate whether infection by AdlacZ4AS caused
epicardial cells to undergo programmed cell death, we per-
formed TUNEL analysis on epicardial cells cultured in
serum-free medium or in sections of grafted hearts. While
we observed TUNEL-positive nuclei in AdlacZ- and
AdlacZ4AS-infected cells both in tissue culture and in
chimeras, there was no additional apoptosis in AdlacZ4AS-
infected cells or engrafted hearts when compared with wild-
type or AdlacZ-infected cells and hearts (not shown). This
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excluded apoptosis as an explanation for the loss of epicar-
dial staining.
We next examined the question of whether engrafted
4-negative cells migrated to anomalous positions within or
around the heart. To do this, we sectioned chimeras fixed
24–48 h after surgery and counted -gal-positive cells in
every section. In all of these grafts, we observed clusters of
-gal-stained cells on the dorsal aspect of the heart (Fig. 2A
and B). For grafts of AdlacZ-infected cells, the clusters
were well attached to the heart, and cells were observed in
the epicardium, subepicardium, and myocardium (Fig. 2A
and C). Clusters of AdlacZ4AS-infected cells were able to
adhere to the chick epicardium (Fig. 2B). Of those cells that
attached to the heart, most migrated directly to the myocar-
dium (Fig. 2B and C). However, in no case did we observe
clumps of AdlacZ4AS-infected cells elsewhere in the peri-
cardial space that had not adhered to the heart, nor did we
observe virus-infected cells in the parietal pericardium, liver
or other surrounding tissues, ruling out anomalous migra-
tion of 4-negative cells outside of the heart.
To investigate epicardial cell development and migra-
tion, we scored the position of 1243 infected cells in the 5
sectioned AdlacZ-infected chimeras fixed 24–48 h after
engraftment (Table 2; Fig. 2). In these chimeras, 37% of the
infected cells were in epicardium, 37% were in the subepi-
cardium, and 26% were in the myocardial interstitium. This
was consistent with our previous study (Dettman et al.,
1998) and demonstrated that the grafted AdlacZ-infected
epicardial cells participated in formation of the epicardium
and underwent epicardial–mesenchymal transformation to
invade the subepicardium and myocardium. In contrast, we
counted 1314 infected cells in 4 AdlacZ4AS engrafted
chimeras and found only 11% of 4-negative cells in the
epicardium, 5% in the subepicardium, while 83% were in
the myocardial interstitium (Table 2; Fig. 2C). These dif-
ferences within each region of the heart were statistically
significant (P  0.05) and indicated that, when epicardial
cells are grafted to the surface of the E2.5 heart,
AdlacZ4AS infection results in a loss of epicardial and
subepicardial phenotype and a significant increase in myo-
cardial positioning. This indicates that 4-negative cells
were more likely to acquire mesenchymal characteristics
and invade deeper into the heart than AdlacZ-infected cells.
We next wondered whether excessive transformation and
migration of epicardial cells continued at later stages of
development. Hence, we analyzed hearts excised from chi-
meric embryos fixed 4 days after transplantation (Table 2;
Fig. 3). In four AdlacZ chimeras, we counted 2964 infected
cells. In these chimeras, the distribution of cells was very
similar to that found after 2 days of incubation (Table 2; Fig.
3C). In the experimental AdlacZ4AS group, we sectioned 7
chimeras and counted 1906 infected cells (Table 2). In these
chimeras, only 2% of the infected cells were found in the
epicardial epithelium, as compared with 28% in the AdlacZ
group (Fig. 3C). In the AdlacZ4AS group, 22% were in the
subepicardium and 76% were in the myocardial interstitium
compared with 44 and 27% in the AdlacZ group (Fig. 3C).
Together, these results are consistent with the hypothesis
that 4-integrin is essential for maintenance of the epithelial
phenotype of engrafted epicardial cells and restrains the
migration of epicardially derived mesenchyme from the
subepicardium to the myocardium.
AdlacZ4AS infection increases epicardial–mesenchymal
transformation and stimulates mesenchymal cell migration
in cultured hearts
Our grafting experiments suggested enhanced epicar-
dial–mesenchymal transformation, invasion, and migration
of engrafted 4-negative epicardial cells. It is possible that
cultured epicardial cells lose some epithelial characteristics
and become mesenchymal prior to grafting. Therefore, in
order to test whether increased epicardial–mesenchymal
transformation in the chimeras was a direct consequence of
the loss of 4-integrin and not an artifact of epicardial cell
culture and/or transplantation, we performed confirmatory
experiments using an in vitro organ culture system (Mora-
bito et al., 2001). E4.5 embryonic hearts were explanted and
infected with recombinant adenovirus. After 24 h in serum-
free medium, we found that 95% of the cells labeled with
either AdlacZ or AdlacZ4AS were in the epicardium, sug-
gesting that virions did not pass through the epicardial
monolayer to infect the subepicardium or myocardium (data
not shown). After 3 days in serum-free medium, hearts were
sectioned and cells scored for their position in the epicardial
epithelium, subepicardial mesenchyme, or myocardial inter-
stitium (Fig. 4A and B). In AdlacZ-infected hearts cultured
in serum-free medium, 83% of the labeled cells were epi-
cardial, while 61% of the infected cells in hearts treated with
AdlacZ4AS were epicardial (Fig. 4C). This observation
confirmed that infection by AdlacZ4AS in epicardial epi-
thelial cells stimulates epicardial–mesenchymal transforma-
tion. Interestingly, despite increased epicardial–mesenchy-
mal transformation by AdlacZ4AS, the fraction of infected
cells in the subepicardial mesenchyme was similar for the
two viral constructs. However, we observed a three-fold
increase in the percentage of labeled cells in the myocardial
interstitium of AdlacZ4AS-infected hearts compared with
AdlacZ-infected hearts (P  0.03), suggesting that, after
epicardial–mesenchymal transformation, AdlacZ4AS-in-
fected mesenchymal cells are more invasive than similar
cells infected with AdlacZ. These results closely mirrored
our transplantation experiments and suggest that 4-integrin
function promotes the epithelial phenotype of cells in the
epicardium and promotes the mesenchymal phenotype of
cells in the subepicardial space.
Increased numbers of AdlacZ4AS-infected cells in the
myocardium and not subepicardium (Fig. 4C) suggested
that the effect of AdlacZ4AS infection on epicardial cells
was to increase migration from the subepicardial space to
the myocardium. To test this hypothesis, we performed
similar organ culture experiments with the addition of
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FGF-2, a known stimulant of epicardial–mesenchymal
transformation (Morabito et al., 2001). We reasoned that, if
we increased the number of infected cells in the mesen-
chyme, we could distinguish the effect of AdlacZ4AS on
subsequent migrations. In hearts infected with AdlacZ and
treated with FGF-2, we observed a decrease in the fraction
of infected cells in the epicardium from about 83 to 65%
(compare Fig. 4C with 5C), indicating that FGF-2 stimu-
lated epicardial–mesenchymal transformation. This in turn
produced a doubling in the fraction of labeled cells in the
subepicardial mesenchyme and in the myocardial intersti-
tium (Fig. 5C).
Interestingly, the addition of FGF-2 did not significantly
alter the percentage of AdlacZ4AS-infected cells in the
epicardium (Fig. 5C), suggesting that epicardial–mesenchy-
mal transformation is already near maximal levels in 4-
negative epicardium. Surprisingly, FGF-2 further stimulated
migration from the subepicardial space so that 2% of
AdlacZ4AS-labeled cells were found there, and there was
a corresponding increase in the number of cells found in the
myocardial interstitium. This implies that the combination
of AdlacZ4AS infection and FGF-2 stimulation act to-
gether to increase migration of infected cells from the sub-
epicardium to myocardium and implicates FGF-2 in regu-
lating migration of epicardially derived mesenchyme.
AdlacZ4AS-infected epicardial cells do not differentiate
into vascular smooth muscle in the myocardium
In our previous study, we found that approximately half
of epicardially derived mesenchyme ultimately ends up in
coronary vascular smooth muscle, 20% are adventitial, and
25% of cells normally remain interstitial (Dettman et al.,
1998). To determine whether the cell fates of epicardially
derived mesenchyme are altered by the loss of 4-integrin,
we analyzed sections from E17.5 grafted hearts containing
quail epicardial cells infected with either AdlacZ or
AdlacZ4AS. All sections containing lacZ-positive cells
were stained with an antibody to smooth muscle-specific
caldesmon, a late-expressed smooth muscle antigen (Mi-
kawa and Gourdie, 1996; Dettman et al., 1998). Caldesmon-
positive cells associated with blood vessels were found in
all sections stained; however, despite the substantial in-
crease in AdlacZ4AS-labeled cells in the myocardial inter-
stitium, cells labeled with the antisense virus were very
rarely colocalized with caldesmon. To quantify the differ-
ence in formation of vascular smooth muscle between epi-
cardial cells infected with AdlacZ and AdlacZ4AS, we
counted the percentage of myocardially localized quail epi-
cardial cells infected with either virus in vascular smooth
muscle 15 days after transplantation (Fig. 6). We observed
few AdlacZ4AS-infected cells within the epicardium, sub-
epicardium, and subepicardial coronaries. This was consis-
tent with the idea that increased numbers of 4-negative
cells in the myocardium were balanced by fewer infected
cells at the surface of the heart. Nonetheless, only infected
cells within the myocardium were counted in this experi-
ment. We observed that, of 961 AdlacZ-infected cells
counted in 4 hearts, 18% of the cells were caldesmon-
positive (Fig. 6C). In contrast, of 593 AdlacZ4AS-infected
cells counted in 5 hearts, only 3.6% of the cells were
caldesmon-positive (P  0.0024; Fig. 6C). This indicated
that, in addition to making epicardial cells more invasive
and migratory, AdlacZ4AS inhibits epicardially derived
mesenchyme from becoming smooth muscle and restricts
them to the interstitial fibroblast phenotype.
AdlacZ4AS inhibition of smooth muscle differentiation
in intermyocardial vessels could occur by two mechanisms.
First, 4-integrin could be required to transduce an induc-
tive signal at the vascular endothelium for the differentia-
tion step of mesenchyme to smooth muscle. Second, 4
could function to direct mesenchymal cells to nascent ves-
sels, where smooth muscle differentiation is induced by a
second factor. Epicardial cells undergo epithelial–mesen-
chymal transformation and begin to express smooth muscle-
specific genes when cultured in serum-supplemented me-
dium (Landerholm et al., 1999). Hence, we tested the ability
of epicardial cells infected with either AdlacZ or
AdlacZ4AS to differentiate into smooth muscle when stim-
ulated with serum in vitro. Epicardial cells were grown on
coverslips coated with fibronectin, infected, and cultured for
3 days in serum-free M199 medium. Infected cells were
treated with PDGF-BB to stimulate smooth muscle differ-
entiation (Lu et al., 2001). After 3 days, the coverslips were
fixed and incubated with either anti-calponin or anti-caldes-
mon (Fig. 7). We observed that virtually all of the mesen-
chymal cells within the collagen gel reacted with both
antibodies, indicating that PDGF-BB stimulated expression
of smooth muscle-specific proteins (Fig. 7). We then in-
spected the mesenchymal cells that expressed GFP and
observed that cells infected with either AdlacZ (Fig. 7A–F)
or AdlacZ4AS (Fig. 7G–L) were both reactive with anti-
calponin (Fig. 7B and H) and anti-caldesmon (Fig. 7D
and J). The ability of AdlacZ4AS-infected epicardial cells
to synthesize the smooth muscle-specific proteins calponin
and caldesmon in vitro suggests that 4-integrin is not
essential for smooth muscle differentiation and suggests that
the relative absence of 4-negative cells from intermyocar-
dial vasculature arises from a failure of targeting of these
cells to vessels.
Discussion
Here, we present evidence that inhibition of chick 4
integrin produces an invasive and migratory phenotype of
epicardial cells. Infection with AdlacZ4AS caused a nearly
complete loss of 4-integrin from the surface of epicardial
cells, stimulated epicardial–mesenchymal transition, and
enhanced the migration of epicardially derived mesenchyme
from the subepicardium to the myocardial interstitium. The
novel antisense strategy we used allowed us to test the
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function of 4 integrin during epicardial development both
in vitro and in vivo. These approaches lend themselves to
the quantitative anatomic and phenotypic analysis of epi-
cardial cell movement, thus demonstrating the utility of the
adenoviral approach. Along with mouse deletion studies
(Yang et al., 1995; Sengbusch et al., 2002), our results
emphasize the importance of 4 in maintaining the integrity
of the epicardium and suggest that integrins may play an
important role in the regulation of epicardial–mesenchymal
transformation, migration, and targeting of epicardially de-
rived mesenchyme to the vascular wall.
Our experiments were designed to investigate the role of
4 during epicardial–mesenchymal transformation and sub-
sequent development. Our organ culture experiments dem-
onstrated that inhibition of 4 increased epicardial–mesen-
chymal transformation. When incubated in serum-free
medium, we observed that there were 22% fewer labeled
cells in the epicardium of AdlacZ4AS-infected hearts (Fig.
5C). Interestingly, this effect was not augmented by the
addition of FGF-2, a potent stimulant of epicardial–mesen-
chymal transformation (Fig. 5B). The observation that max-
imal epicardial–mesenchymal transformation is produced
by FGF-2 stimulation or downregulation of 4 integrin
suggests the intriguing hypothesis that FGF-2 regulates epi-
cardial–mesenchymal transformation by removing 4 from
the cell surface. Subsequent reexpression of 4 integrin is
then required to target mesenchymal cells to the developing
blood vessel.
Our results are consistent with the recent phenotype
generated by the 4lacZ knock-in, null allele (4KI-lacZ)
in which proepicardial cells were able to adhere to the heart
and divide, but failed to migrate over the myocardial surface
(Sengbusch et al., 2002). Proepicardial organs excised from
4KI-lacZ homozygous embryos were able to adhere to FN
but not VCAM-1. This demonstrated that proepicardial cells
express an additional FN receptor. One candidate is 51 as
Sengbusch et al. (2002) and we have observed 5 accumu-
lation in epicardial cells (unpublished data). However,
4KI-lacZ proepicardial cells are unable to migrate on FN
or myocardium, indicating that FN receptor(s) in proepicar-
dial cells cannot mediate proepicardial cell migration in the
absence of 4 and implicate 4 as the prime mediator of
proepicardial cell migration on myocardium.
Our observation that AdlacZ4AS infection stimulates
mesenchymal cell invasion differs from the phenotype of
4KI-lacZ epicardial cells seen by Sengbusch et al. (2002),
who did not observe an accumulation of lacZ cells in the
E10.5 myocardium. This may well be a consequence of the
fact that 4-null mice are dying at E10.5 and do not live
long enough for epicardial cells to migrate the distances
seen in our experiments. This difference highlights what we
believe are several important strengths of our antisense
strategy and the use of quail/chick chimeras. First, we trans-
plant a pure population of epicardial cells so that precursor–
product relationships are straightforward. Second, our viral
construct ensures that labeling and genetic alteration of
epicardial cells are simultaneous so that all labeled cells are
depleted of 4-integrin and all 4-negative cells are labeled.
Third, the fate of transplanted cells is evaluated in a normal
developmental context without secondary effects attribut-
able to poor health of the embryo or genetic alteration of
cells outside of the population of interest. And finally, the
use of adenovirus lends itself to quantitative analysis of cell
migration and fate determination. This strategy should be
generally applicable in analysis of any cell-autonomous
target.
What is the general role of 4-integrin in the regulation
of cell migration? The answer to this elusive question seems
to depend on the cellular context in which 4-integrins are
found. A variety of studies employing blocking antisera,
soluble ligands, and antisense oligonucleotides all suggest
that 4-integrin is essential for normal migration of neural
Fig. 7. Infection of epicardial cells with AdlacZ4AS does not inhibit their expression of calponin or caldesmon in vitro. Views of epicardially derived
mesenchymal cells on fibronectin-coated coverslips infected with either AdlacZ (A–F) or AdlacZ4AS (G–L). (A, C, E, G, I, K) GFP expression resulting
from adenoviral infection in representative cells (green). (B, H) Mesenchymal cells that react with anti-calponin (red). (D, J) Mesenchymal cells that react
with anti-caldesmon (red). Calponin and caldesmon are actin-associated proteins that colocalize with thin filaments. (E, L) A control experiment in which
the primary antibody was omitted. Magnification bar in (L) represents 40 m.
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crest (Kil et al., 1996, 1998; Testaz et al., 1999; Testaz and
Duband 2001). In other cell-types, 4 has been implicated
primarily as an adhesion receptor. For example, in LB
lymphoma cells (Gosslar et al., 1996), melanoma cells
(Qian et al., 1994), and sarcoma cells (Beauvais et al.,
1995), overexpression of 41 limited invasive and migra-
tory properties. There is evidence that the 4 subunit can act
as a homophilic ligand for the 41 and 47 receptors and
promote clustering of lymphoid cells (Altevogt et al., 1995).
In mouse 4-null chimeras, erythroid progenitors and pre-B
cells failed to migrate beneath the stroma, while at the same
time, 4-null cells migrated and differentiated into T lym-
phocytes in the thymus (Arroyo et al., 1999).
The ability of 4-integrin to sometimes facilitate migra-
tion and at other times to suppress it may be explained by at
least two mechanisms. First, the level of 4 expression may
influence its function. For example, low 4-expressing sar-
coma cells were invasive when injected into neural crest
migratory paths, while high-expressing cells aggregated and
failed to migrate (Beauvais et al., 1995). Similarly, increas-
ing 4 expression in cancer cells inhibits their migration
during metastasis (Qian et al., 1994; Gosslar et al., 1996).
Expression levels may also vary in emigrating neural crest
with low levels of 4 in some migrating cells and high
levels in stationary cells (Kil et al., 1998; Testaz et al.,
1999). Our results in which epicardial cells with decreasing
levels of 4 migrate more avidly from the subepicardium to
the myocardium are consistent with the idea that low levels
of 4 promote migration while high levels promote adhe-
sion.
A second mechanism that could mediate the function of
4 containing integrins is through integrin cytoplasmic do-
main-binding proteins (Liu et al., 1999, 2000; Liu and
Ginsberg, 2000). When the cytoplasmic tail of 4 was
joined to other -subunits, cells became more migratory and
less adhesive (Kassner et al., 1995). Paxillin, an intracellular
adaptor protein has been shown to bind to the cytoplasmic
domain of 4 and not other  tails (Liu et al., 1999). In cell
binding experiments to VCAM-1, paxillin null cells were
capable of spreading, but when paxillin expression was
restored, spreading was inhibited (Liu et al., 1999). Paxillin
mediates the interaction of 4-containing integrins with
other cytoplasmic proteins that mediate cell migration and
cytoskeletal organization (Turner, 1998; Liu et al., 2000).
Investigation of integrin cytoplasmic tail-binding proteins in
the embryonic heart may lead to a better understanding of
the molecular regulation of epicardial–mesenchymal trans-
formation and migration of epicardially derived mesen-
chyme.
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